Heregulin-dependent delay in mitotic progression requires HER4 and BRCA1
Rebecca S Muraoka-Cook1, Laura S Caskey, Melissa A Sandahl
1Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, 102 Mason Farm Road, Chapel Hill, NC 27599, USA.
Abstract:
HER4 expression in human breast cancers correlates with a positive prognosis. While heregulin inhibits the growth of HER4-positive breast cancer cells, it does so by undefined mechanisms. We demonstrate that heregulin-induced HER4 activity inhibits cell proliferation and delays G(2)/M progression of breast cancer cells. While investigating pathways of G(2)/M delay, we noted that heregulin increased the expression of BRCA1 in a HER4-dependent, HER2-independent manner. Induction of BRCA1 by HER4 occurred independently of the cell cycle. Moreover, BRCA1 expression was elevated in HER4-postive human breast cancer specimens. Heregulin stimulated c-Jun N-terminal kinase (JNK), and pharmacologic inhibition of JNK impaired heregulin-enhanced expression of BRCA1 and mitotic delay; inhibition of Erk1/2 did not. Knockdown of BRCA1 with small interfering RNA in a human breast cancer cell line interfered with HER4-mediated mitotic delay. Heregulin/HER4-dependent mitotic delay was examined further with an isogenic pair of mouse mammary epithelial cells (MECs) derived from mice harboring homozygous LoxP sites flanking exon 11 of BRCA1, such that one cell line expressed BRCA1 while the other cell line, after Cre-mediated excision, did not. BRCA1-positive MECs displayed heregulin-dependent mitotic delay; however, the isogenic BRCA1-negative MECs did not. These results suggest that heregulin-mediated growth inhibition in HER4-postive breast cancer cells requires BRCA1.
Insights
Heregulin inhibits HER4-positive breast cancer cell growth by increasing BRCA1 expression, which is crucial for mitotic delay and tumor suppression. This discovery offers new insights into breast cancer treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- HER4 expression in breast cancer indicates a positive prognosis.
- The mechanisms by which heregulin inhibits HER4-positive breast cancer cells are not fully understood.
Purpose of the Study:
- To elucidate the mechanisms underlying heregulin's inhibition of HER4-positive breast cancer cell growth.
- To investigate the role of BRCA1 in heregulin-mediated effects on breast cancer cells.
Main Methods:
- Demonstrated heregulin-induced HER4 activity inhibits proliferation and delays G2/M progression.
- Investigated BRCA1 expression changes in response to heregulin and HER4.
- Utilized JNK and Erk1/2 pathway inhibitors.
- Employed small interfering RNA for BRCA1 knockdown.
- Used isogenic mouse mammary epithelial cells with and without BRCA1.
Main Results:
- Heregulin increased BRCA1 expression in a HER4-dependent, HER2-independent manner.
- BRCA1 induction by HER4 occurred independently of the cell cycle and was elevated in HER4-positive human breast cancer specimens.
- JNK activation by heregulin was linked to BRCA1 expression and mitotic delay, while Erk1/2 was not.
- BRCA1 knockdown abrogated heregulin-mediated mitotic delay.
- BRCA1-positive cells showed heregulin-dependent mitotic delay, unlike BRCA1-negative cells.
Conclusions:
- Heregulin-mediated growth inhibition in HER4-positive breast cancer cells requires BRCA1.
- BRCA1 plays a critical role in the heregulin/HER4 signaling pathway, mediating mitotic delay and contributing to tumor suppression.
- These findings suggest BRCA1 as a potential therapeutic target in heregulin/HER4-driven breast cancers.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Mitogens and the Cell Cycle
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...


